UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 345

Sortiert nach

Using Real-World Data to Predict Findings of an Ongoing Phase IV Cardiovascular Outcome Trial: Cardiovascular Safety of Linagliptin Versus Glimepiride

Diabetes care, 2019-12, Vol.42 (12), p.2204-2210

2019

Volltextzugriff (PDF)

Failure of Investigational Drugs in Late-Stage Clinical Development and Publication of Trial Results

JAMA internal medicine, 2016-12, Vol.176 (12), p.1826

2016

Volltextzugriff (PDF)

Emulation Differences vs. Biases When Calibrating Real‐World Evidence Findings Against Randomized Controlled Trials

Clinical pharmacology and therapeutics, 2020-04, Vol.107 (4), p.735-737

2020

Volltextzugriff (PDF)

Persistent opioid use following cesarean delivery: patterns and predictors among opioid-naïve women

American journal of obstetrics and gynecology, 2016-09, Vol.215 (3), p.353.e1-353.e18

2016

Volltextzugriff (PDF)

Real‐world evidence to support regulatory decision‐making for medicines: Considerations for external control arms

Pharmacoepidemiology and drug safety, 2020-10, Vol.29 (10), p.1228-1235

2020

Volltextzugriff (PDF)

Using Super Learner Prediction Modeling to Improve High-dimensional Propensity Score Estimation

Epidemiology (Cambridge, Mass.), 2018-01, Vol.29 (1), p.96-106

2018

Volltextzugriff (PDF)

Comparison of rates of safety issues and reporting of trial outcomes for medical devices approved in the European Union and United States: cohort study

BMJ (Online), 2016-06, Vol.353, p.i3323

2016

Volltextzugriff (PDF)

An evaluation of longitudinal changes in serum uric acid levels and associated risk of cardio-metabolic events and renal function decline in gout

PloS one, 2018-02, Vol.13 (2), p.e0193622-e0193622

2018

Volltextzugriff (PDF)

Implications of the Propensity Score Matching Paradox in Pharmacoepidemiology

American journal of epidemiology, 2018-09, Vol.187 (9), p.1951-1961

2018

Volltextzugriff (PDF)

Variable Selection for Confounding Adjustment in High-dimensional Covariate Spaces When Analyzing Healthcare Databases

Epidemiology (Cambridge, Mass.), 2017-03, Vol.28 (2), p.237-248

2017

Volltextzugriff (PDF)

When and How Can Real World Data Analyses Substitute for Randomized Controlled Trials?

Clinical pharmacology and therapeutics, 2017-12, Vol.102 (6), p.924-933

2017

Volltextzugriff (PDF)

Claims‐based studies of oral glucose‐lowering medications can achieve balance in critical clinical variables only observed in electronic health records

Diabetes, obesity & metabolism, 2018-04, Vol.20 (4), p.974-984

2018

Volltextzugriff (PDF)

Prevalence, predictors, and outcomes of both true- and pseudo-resistant hypertension in the action to control cardiovascular risk in diabetes trial: a cohort study

Hypertension research, 2021-11, Vol.44 (11), p.1471-1482

2021

Volltextzugriff (PDF)

Physicians' Knowledge About FDA Approval Standards and Perceptions of the "Breakthrough Therapy" Designation

JAMA : the journal of the American Medical Association, 2016-04, Vol.315 (14), p.1516

2016

Volltextzugriff (PDF)

Effects of expanding the look‐back period to all available data in the assessment of covariates

Pharmacoepidemiology and drug safety, 2017-08, Vol.26 (8), p.890-899

2017

Volltextzugriff (PDF)

Predicting overdose among individuals prescribed opioids using routinely collected healthcare utilization data

PloS one, 2020-10, Vol.15 (10), p.e0241083

2020

Volltextzugriff (PDF)

Variations in Patients' Perceptions and Use of Generic Drugs: Results of a National Survey

Journal of general internal medicine : JGIM, 2016-06, Vol.31 (6), p.609-614

2016

Volltextzugriff (PDF)

Chronic hypertension in pregnancy and the risk of congenital malformations: a cohort study

American journal of obstetrics and gynecology, 2015-03, Vol.212 (3), p.337.e1-337.e14

2015

Volltextzugriff (PDF)

Heterogeneity of antidiabetic treatment effect on the risk of major adverse cardiovascular events in type 2 diabetes: a systematic review and meta-analysis

Cardiovascular diabetology, 2020-09, Vol.19 (1), p.154-11, Article 154

2020

Volltextzugriff (PDF)

Evaluating the Use of Nonrandomized Real‐World Data Analyses for Regulatory Decision Making

Clinical pharmacology and therapeutics, 2019-04, Vol.105 (4), p.867-877

2019

Volltextzugriff (PDF)

Claims Data Studies of Direct Oral Anticoagulants Can Achieve Balance in Important Clinical Parameters Only Observable in Electronic Health Records

Clinical pharmacology and therapeutics, 2019-04, Vol.105 (4), p.979-993

2019

Volltextzugriff (PDF)

Risk of Venous Thromboembolism in Patients with Rheumatoid Arthritis: Initiating Disease-Modifying Antirheumatic Drugs

The American journal of medicine, 2015-05, Vol.128 (5), p.539.e7-539.e17

2015

Volltextzugriff (PDF)

A correlation analysis to assess event-free survival as a trial-level surrogate for overall survival in early breast cancer

EClinicalMedicine, 2021-02, Vol.32, p.100730-100730, Article 100730

2021

Volltextzugriff (PDF)

How well can we assess the validity of non-randomised studies of medications? A systematic review of assessment tools

BMJ open, 2021-03, Vol.11 (3), p.e043961-e043961

2021

Volltextzugriff (PDF)

The effect of federal and state off-label marketing investigations on drug prescribing: The case of olanzapine

PloS one, 2017-04, Vol.12 (4), p.e0175313-e0175313

2017

Volltextzugriff (PDF)

1 – 25 von 345

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(324)
Mit Volltextzugriff
(291)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(265)
Life Sciences & Biomedicine
(238)
Humans
(212)
Male
(122)
Female
(121)
Middle Aged
(80)
Adult
(78)
Aged
(70)
General & Internal Medicine
(49)
Medicine, General & Internal
(47)
Risk Factors
(44)
Public, Environmental & Occupational Health
(42)
United States
(39)
Cohort Studies
(36)
Patients
(36)
Biological And Medical Sciences
(35)
Pharmacology & Pharmacy
(34)
Medical Sciences
(32)
Propensity Score
(31)
Young Adult
(29)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

Using Real-World Data to Predict Findings of an Ongoing Phase IV Cardiovascular Outcome Trial: Cardiovascular Safety of Linagliptin Versus Glimepiride

Failure of Investigational Drugs in Late-Stage Clinical Development and Publication of Trial Results

Emulation Differences vs. Biases When Calibrating Real‐World Evidence Findings Against Randomized Controlled Trials

Persistent opioid use following cesarean delivery: patterns and predictors among opioid-naïve women

Real‐world evidence to support regulatory decision‐making for medicines: Considerations for external control arms

Using Super Learner Prediction Modeling to Improve High-dimensional Propensity Score Estimation

Comparison of rates of safety issues and reporting of trial outcomes for medical devices approved in the European Union and United States: cohort study

An evaluation of longitudinal changes in serum uric acid levels and associated risk of cardio-metabolic events and renal function decline in gout

Implications of the Propensity Score Matching Paradox in Pharmacoepidemiology

Variable Selection for Confounding Adjustment in High-dimensional Covariate Spaces When Analyzing Healthcare Databases

When and How Can Real World Data Analyses Substitute for Randomized Controlled Trials?

Claims‐based studies of oral glucose‐lowering medications can achieve balance in critical clinical variables only observed in electronic health records

Prevalence, predictors, and outcomes of both true- and pseudo-resistant hypertension in the action to control cardiovascular risk in diabetes trial: a cohort study

Physicians' Knowledge About FDA Approval Standards and Perceptions of the "Breakthrough Therapy" Designation

Effects of expanding the look‐back period to all available data in the assessment of covariates

Predicting overdose among individuals prescribed opioids using routinely collected healthcare utilization data

Variations in Patients' Perceptions and Use of Generic Drugs: Results of a National Survey

Chronic hypertension in pregnancy and the risk of congenital malformations: a cohort study

Heterogeneity of antidiabetic treatment effect on the risk of major adverse cardiovascular events in type 2 diabetes: a systematic review and meta-analysis

Evaluating the Use of Nonrandomized Real‐World Data Analyses for Regulatory Decision Making

Claims Data Studies of Direct Oral Anticoagulants Can Achieve Balance in Important Clinical Parameters Only Observable in Electronic Health Records

Risk of Venous Thromboembolism in Patients with Rheumatoid Arthritis: Initiating Disease-Modifying Antirheumatic Drugs

A correlation analysis to assess event-free survival as a trial-level surrogate for overall survival in early breast cancer

How well can we assess the validity of non-randomised studies of medications? A systematic review of assessment tools

The effect of federal and state off-label marketing investigations on drug prescribing: The case of olanzapine

Suchergebnisse filtern